This is a concise review of up-to-date concepts and techniques in the discipline of heart transplantation. It is a review and reference for practitioners managing patients with advanced heart disease, including patients with end-stage heart failure, mechanical circulatory support or transplant recipients. Heart failure is a major public health issue, with a prevalence of over 5.8 million in the USA, and over 23 million worldwide, and rising. The lifetime risk of developing heart failure is one in five. Heart failure carries substantial morbidity and mortality, with 5-year mortality that rival those of many cancers. As heart transplantation remains the best treatment option for patients with end stage heart failure, this primer will provide valuable information and management strategies for physicians caring for these patients. Also, due to continued shortage in donor organs, heart transplantation is a limited resource - which further underscores the importance of appropriately evaluating patients for transplant candidacy and managing their pre, peri- and post-transplant care for maximum benefit and best outcomes.
Rezensionen / Stimmen
"This is a current, concise review of best practices and concepts regarding the pathophysiology and treatment issues in cardiac transplantation. . This succinct resource would be useful for practitioners at all levels of training and practice. From medical students to residents and fellows to cardiologists, the book provides the necessary tools to help manage and treat patients being prepared for, and who undergo, cardiac transplantation. It measures up to any cardiac transplantation review book in the field." (John Barr Biglane, Doody's Book Reviews, July, 2017)
Auflage
Softcover reprint of the original 1st ed. 2017
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Illustrationen
25
25 farbige Abbildungen, 25 s/w Abbildungen
XII, 258 p. 50 illus., 25 illus. in color.
Maße
Höhe: 254 mm
Breite: 178 mm
Dicke: 14 mm
Gewicht
ISBN-13
978-3-319-82907-4 (9783319829074)
DOI
10.1007/978-3-319-43773-6
Schweitzer Klassifikation
Jon Kobashigawa, MD, is the DSL/Thomas D. Gordon professor of Medicine, director of the Advanced Heart Disease Section, director of the Heart Transplant Program and the associate director of the Cedars-Sinai Heart Institute as well as the associate director of the Comprehensive Transplant Center of the Cedars-Sinai Medical Center.
He received his undergraduate degree at Stanford University and earned his medical degree at Mount Sinai School of Medicine in New York. He is a past president of the International Society of Heart and Lung Transplantation, past chair of the American College of Cardiology Committee on Heart Failure and Transplantation, and past member of the United Network of Organ Sharing National Thoracic Committee.
Dr. Kobashigawa is recognized nationally and internationally as a leader in heart transplantation. He has published more than 300 peer-reviewed articles, chapters and monographs in the field of heart failure and transplantation and has chairedseveral multicenter clinical studies. Dr. Kobashigawa has organized and chaired several International Consensus Conferences to discuss pertinent questions regarding heart failure and heart transplant. He lectures at universities around the world and has mentored several young physicians who have ascended to important academic positions throughout the country.
Introduction.- Options for Patients with End-Stage Heart Failure.- Evaluation of Heart Transplant Candidacy.- Listing Criteria and Process.- Optimal Management of Patients on the Heart Transplant Waiting List.- Histocompatibility Testing and Cross Matching.- The Sensitized Patient Awaiting Heart Transplantation.- Donor Organ Preservation and Surgical Considerations in Heart Transplantation.- Immediate Post-Operative Period.- Immunosuppression Strategies in Heart Transplantation.- Rejection Surveillance and Treatment in the First Year.- Out-Patient Management of the Heart Transplant Patient.- Long-Term Complications in Heart Transplantation.- The Total Artificial Heart.- Chimerism and Tolerance.- Genomics In Heart Transplantation.- The Future of Heart Transplantation.
